Aims: Firstly, to compare rates of surgery for non-cardiac vascular disease in Caucasians and Asians and secondarily to assess the prevalence of peripheral arterial disease (PAD) and abdominal aortic aneurysm (AAA) in the male UK Asian population.

Methods: Analysis of a prospective database followed by an epidemiological survey of 100 unselected Pakistani males, in which demographic and anthropometric data were collected alongside aortic ultrasonography and measurement of ankle: brachial pressure index (ABPI).

Results: Although 14.1% of our catchment area is Asian, after correction for age, they only accounted for 64/2268 (2.8%) of procedures for PAD and AAA. Specifically, Asians were 10 times less likely to undergo AAA repair and 3 times less likely to undergo procedures for lower limb peripheral bypass, amputation and endovascular intervention. In the epidemiological study, 26 subjects had a significant history of ischaemic heart disease, 21 were diabetic, 32 had hypertension and 60 were current or ex-smokers. Median aortic diameter [IQR] was 17.6 mm [16.3-19.1 mm] and no subject had an AAA. In 200 limbs, median ABPI [IQR] was 1.12 [1.04-1.21]. Only 2 patients had an ABPI < 0.9.

Conclusion: Despite a high prevalence of cardiovascular risk factors and ischaemic heart disease, the prevalence of PAD and AAA is much lower than would have been expected in an age- and sex-matched Caucasian population. These data suggest that the reduced incidence of surgery for PAD and AAA in UK Asians is due to a low prevalence of disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejvs.2006.03.010DOI Listing

Publication Analysis

Top Keywords

pad aaa
12
incidence surgery
8
surgery non-cardiac
8
non-cardiac vascular
8
vascular disease
8
low prevalence
8
prevalence disease
8
aaa asians
8
times undergo
8
ischaemic heart
8

Similar Publications

There is currently no clinically valid biomarker for predicting the growth and prognosis of abdominal aortic aneurysms (AAA). The most promising candidates with the highest diagnostic values are plasma D-dimers and markers of activated neutrophils, i.e.

View Article and Find Full Text PDF

Background: This review provides an overview of the literature on shared decision-making (SDM) in patients with abdominal aortic aneurysm (AAA) or peripheral artery disease (PAD) and identifies barriers and facilitators.

Methods: A systematic scoping review was conducted, in which 4 databases were systematically searched for the period January 2007 to November 2024. All articles were reviewed by 2 independent authors and asses for quality using the mixed-methods appraisal tool (MMAT).

View Article and Find Full Text PDF
Article Synopsis
  • * Studies show that a genetically determined increase in lipoprotein(a) by 50 mg/dl raises the risk for PAD and AAA, with hazard ratios indicating significantly higher risks for individuals in the top percentile of lipoprotein(a) levels compared to those in the lower percentile.
  • * The review emphasizes the importance of providing clinicians with risk prediction tools and suggests that reducing lipoprotein(a) through future therapies could lessen the negative health
View Article and Find Full Text PDF

Background: Abdominal aortic aneurysm (AAA) development is driven by inflammation, in particular myeloid cells, which represent attractive biomarker candidates. Yet to date, the maximum aortic diameter is the only clinically applied predictor of AAA progression and indicator for surgical repair. We postulated that aortic inflammation is reflected in a systemic change of monocyte populations, which we investigated regarding marker potential in AAA diagnosis and prognosis.

View Article and Find Full Text PDF
Article Synopsis
  • RECIST criteria for assessing cancer therapy response, especially for bevacizumab, are often insufficient compared to new radiological biomarkers like tumor-to-liver density (TTLD) ratio and modified size-based criteria.
  • A study analyzing 79 out of 137 colorectal cancer liver metastases (CRLM) patients found that a TTLD ratio greater than 0.6 at baseline was a significant predictor for longer progression-free and overall survival, while tumor size reduction did not correlate with TTLD variations.
  • The findings support the use of TTLD ratio as an early indicator of long-term clinical outcomes and its association with improved perfusion parameters in patients undergoing treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!